chevron_leftBack
As of 22 June 2026, Atlantic International Corp. has a market cap of $41.96M USD, ranking #31804 globally and #4589 in the United States.
It ranks #2875 in the Healthcare sector, and #999 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$41.96MUSD
Enterprise Value
$255.83MUSD
Revenue (TTM)
$435.88MUSD
EBITDA (TTM)
-$45.3MUSD
Net Income (TTM)
-$59.43MUSD
EBITDA Margin
-10%
Profit Margin
-14%
PS Ratio
0.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jeffrey Jagid
open_in_new
Employees
300
Founded
2014
IPO
27 Aug 2021
Website
atlantic-international.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -15% | -12% | -45% | -49% | -35% | -50% |
News
Loading...
ATLN Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ATLN
Atlantic International Corp
ISIN: US0485921094
Shares Out.:
Shares Outstanding:
76.227M1
Shares Float:
24.392M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
1.76 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Atlantic International Corp.
Atlantic International Corp. operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals. The company specializes in permanent, temporary, and temporary-to-permanent placement services in various areas, including accounting and finance, administrative and clerical, hospitality, information technology, legal, staffing, light industrial, and medical fields. It also provides productivity consulting and workforce management solutions. The company was founded in 2018 and is based in Englewood Cliffs, New Jersey.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
2M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
1M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
859K%
|
97.4
|
|
NYSE: MRK
|
$274.03B
653K%
|
15.1
|
|
NYSE: PFE
|
$149.38B
356K%
|
19.5
|
|
NYSE: BMY
|
$117.58B
280K%
|
16.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SIX: RO
|
$318.3B
759K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
678K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$271.9B
648K%
218.9B CHF
|
20.5
|
|
CPH: NOVO-B
|
$180.26B
430K%
1.18T DKK
|
11.5
|
|
EPA: SAN
|
$109.16B
260K%
95.26B EUR
|
19.9
|
|
LSE: GSK
|
$106.89B
255K%
80.96B GBP
|
14.6
|
chevron_leftBack